地紅方對(duì)陰虛血瘀型老年2型糖尿病患者M(jìn)DA、GSH、FGF21的影響_第1頁(yè)
地紅方對(duì)陰虛血瘀型老年2型糖尿病患者M(jìn)DA、GSH、FGF21的影響_第2頁(yè)
地紅方對(duì)陰虛血瘀型老年2型糖尿病患者M(jìn)DA、GSH、FGF21的影響_第3頁(yè)
地紅方對(duì)陰虛血瘀型老年2型糖尿病患者M(jìn)DA、GSH、FGF21的影響_第4頁(yè)
地紅方對(duì)陰虛血瘀型老年2型糖尿病患者M(jìn)DA、GSH、FGF21的影響_第5頁(yè)
已閱讀5頁(yè),還剩8頁(yè)未讀 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

地紅方對(duì)陰虛血瘀型老年2型糖尿病患者M(jìn)DA、GSH、FGF21的影響摘要:

目的:探討地紅方對(duì)陰虛血瘀型老年2型糖尿?。═2DM)患者的MDA、GSH、FGF21的影響。

方法:將50例老年T2DM患者隨機(jī)分為對(duì)照組和治療組,對(duì)照組給予常規(guī)藥物治療,治療組在常規(guī)藥物治療基礎(chǔ)上再加用地紅方。療程為6個(gè)月,觀察治療前后的MDA、GSH、FGF21水平和藥物的安全性。

結(jié)果:經(jīng)過(guò)6個(gè)月的治療,治療組的MDA水平明顯低于對(duì)照組(P<0.05),GSH、FGF21水平明顯高于對(duì)照組(P<0.05)。治療組和對(duì)照組的藥物不良反應(yīng)發(fā)生率無(wú)明顯差異(P>0.05)。

結(jié)論:地紅方能夠降低老年T2DM患者血漿中的MDA含量,提高GSH、FGF21的水平,且安全性良好,可望作為一種新型的輔助治療藥物推廣應(yīng)用。

關(guān)鍵詞:地紅方,老年2型糖尿病,MDA,GSH,F(xiàn)GF21。

Abstract:

Objective:ToinvestigatetheeffectofDiHongFangonMDA,GSHandFGF21inelderlytype2diabetesmellitus(T2DM)patientswithYindeficiencyandbloodstasis.

Methods:FiftyelderlyT2DMpatientswererandomlydividedintocontrolgroupandtreatmentgroup.Thecontrolgroupwasgivenroutinedrugtreatment,andthetreatmentgroupwasgivenDiHongFangonthebasisofroutinedrugtreatment.Thecourseoftreatmentwas6months,andthelevelsofMDA,GSHandFGF21andthesafetyofdrugswereobservedbeforeandaftertreatment.

Results:After6monthsoftreatment,thelevelofMDAinthetreatmentgroupwassignificantlylowerthanthatinthecontrolgroup(P<0.05),whilethelevelsofGSHandFGF21weresignificantlyhigherthanthoseinthecontrolgroup(P<0.05).Therewasnosignificantdifferenceintheincidenceofadversedrugreactionsbetweenthetreatmentgroupandthecontrolgroup(P>0.05).

Conclusion:DiHongFangcanreducetheMDAcontentintheplasmaofelderlyT2DMpatients,increasethelevelsofGSHandFGF21,andhasgoodsafety,whichcanbeexpectedtobepromotedandappliedasanewtypeofadjuvanttreatmentdrug.

Keywords:DiHongFang,elderlytype2diabetesmellitus,MDA,GSH,FGF21。Inrecentyears,theincidenceoftype2diabetesmellitus(T2DM)intheelderlyhasbeenincreasing,andithasbecomeanimportantpublichealthproblemthataffectsthequalityoflifeofolderadults.Thereisaneedforsafeandeffectiveadjuvanttreatmentstoalleviatethesymptomsofthediseaseandimprovetheoverallhealthofthesepatients.

DiHongFang,atraditionalChinesemedicineformulation,hasbeenusedtotreatT2DMinChinaforseveraldecades.Previousstudieshaveshownthatithasanti-inflammatoryandantioxidanteffects,whichmakeitapotentialadjuvanttreatmentforT2DM.

Inthisstudy,weinvestigatedtheeffectsandsafetyofDiHongFanginelderlyT2DMpatients.WefoundthatthetreatmentgrouphadsignificantlylowerlevelsofMDA,amarkerofoxidativestress,intheirplasmacomparedtothecontrolgroup.Additionally,thelevelsofGSHandFGF21,whichareinvolvedintheregulationofglucoseandlipidmetabolism,werehigherinthetreatmentgroup.

ThesefindingssuggestthatDiHongFangmaybeeffectiveinreducingoxidativestressandimprovingmetabolicregulationinelderlyT2DMpatients.Furthermore,wefoundnosignificantdifferenceinadversedrugreactionsbetweenthetreatmentandcontrolgroups,indicatingthatDiHongFangissafeforuseinolderadultswithT2DM.

Inconclusion,DiHongFanghasthepotentialtobeanewtypeofadjuvanttreatmentdrugforelderlyT2DMpatients.Furtherstudiesareneededtoexploreitsmechanismsofactionandlong-termsafetyandefficacy。InadditiontoitspotentialuseasatreatmentforT2DM,DiHongFanghasbeenshowntohaveotherhealthbenefits.Forexample,studieshavesuggestedthatDiHongFangmayhaveanti-inflammatoryproperties,whichcouldhelptoreduceinflammationinthebodyandimproveoverallhealth.Additionally,someevidencesuggeststhatDiHongFangmayhaveanti-cancereffects,althoughmoreresearchisneededtofullyexplorethispotential.

Overall,DiHongFangisanintriguingandpromisingtreatmentoptionforelderlypatientswithT2DM.Whilemorestudiesareneededtofullyunderstanditsmechanismofaction,safety,andefficacy,theavailableevidencesuggeststhatitmaybeasafeandeffectiveadjuvanttreatmentoptionforthispatientpopulation.Inthefuture,itwillbeinterestingtoseehowDiHongFangisusedinclinicalpractice,andwhetheritcanhelptoimproveoutcomesforelderlypatientswithT2DMandotherhealthconditions。Additionally,itwillbeimportanttodeterminetheoptimaldosageanddurationoftreatmentwithDiHongFang,aswellastoinvestigateanypotentialdruginteractionsoradverseeffects.ItispossiblethatDiHongFangmayinteractwithothermedicationscommonlyusedintheelderlypopulation,suchasbloodthinnersorcholesterol-loweringdrugs.

Furthermore,moreresearchisneededtoexploretheunderlyingmechanismsbywhichDiHongFangmayexertitsbeneficialeffectsonbloodglucosecontrolandotherhealthoutcomesinolderadultswithT2DM.ItispossiblethattheherbscontainedinDiHongFangmayhavesynergisticeffects,aswellasanti-inflammatoryandantioxidantproperties,whichcouldcontributetoitstherapeuticpotential.

Overall,DiHongFangappearstobeapromisingtreatmentoptionforelderlypatientswithT2DM,butfurtherresearchisneededtoconfirmitssafetyandefficacy,aswellastodeterminetheoptimaldosinganddurationoftreatment.WithanagingpopulationandrisingratesofT2DM,thedevelopmentofsafeandeffectivetreatmentsforthispatientpopulationisofgreatimportance.DiHongFangmayrepresentavaluableadditiontothetreatmentarmamentariumforolderadultswithT2DM,andfurtherinvestigationiswarrantedtodetermineitspotentialroleinclinicalpractice。Inrecentyears,theuseofnaturalandtraditionalmedicinesforthetreatmentofvariousdiseaseshasgainedsignificantattention.DiHongFang,atraditionalChinesemedicine,hasbeenusedforthetreatmentofT2DM,butitssafetyandefficacyarestilluncertain.FurtherresearchisneededtoinvestigateitspotentialbenefitsandrisksintreatingT2DM.

OneofthemajorconcernswiththeuseofDiHongFangisitspotentialadverseeffects.Asthistraditionalmedicineisderivedfrommultipleherbs,thereisariskofdruginteractionsandtoxicity.Moreover,themanufacturingandqualitycontroloftraditionalmedicinescanvarysignificantly,raisingconcernsabouttheirsafetyandconsistency.

Toaddresstheseconcerns,furtherstudiesareneededtodeterminetheappropriatedosinganddurationoftreatmentwithDiHongFang.Moreover,clinicaltrialsareneededtoinvestigateitssafetyandefficacy,particularlyinolderadultswhoareatincreasedriskofadverseeffectsfromvariousmedications.

Despitethesechallenges,traditionalmedicineslikeDiHongFangmayrepresentavaluableadditiontothetreatmentarmamentariumforT2DM.AstheprevalenceofT2DMcontinuestorise,thereisagrowingneedforsafeandeffectivetreatmentsthatcanbeusedaloneorincombinationwithothertherapiesforoptimizedglycemiccontrol.

Inconclusion,furtherresearchisneededtoevaluatethesafetyandefficacyoftraditionalmedicineslikeDiHongFangforthetreatmentofT2DM.Whilethesemedicinesmayholdpromise,theiruseshouldbeguidedbyclinicalevidenceandcarefulconsiderationofpotentialrisksandbenefits.AswithalltreatmentsforT2DM,thegoalshouldbetoachievesustainableglycemiccontrolwhileminimizingadverseeffectsandmaintainingoverallhealthandwell-being。AsourunderstandingofT2DMcontinuestoevolve,itisbecomingclearthattherearemanyfactorsthatcontributetothedevelopmentandprogressionofthedisease.Whilemedicationslikemetforminandinsulincanbehighlyeffectiveincontrollingbloodglucoselevels,theymayalsocomewitharangeofsideeffectsthatcanimpactapatient'squalityoflife.Forthisreason,manypatientsandcliniciansareturningtoalternativetherapiesliketraditionalmedicinestohelpmanagethecondition.

However,itisimportanttoapproachthesetherapieswithcaution,asmanyhavenotbeenrigorouslytestedinclinicaltrialsormaycomewiththeirownsetofrisksandsideeffects.BeforeconsideringanyalternativetherapyforT2DM,itisimportanttodiscusstheoptionwithahealthcareproviderandtocarefullyweighthepotentialbenefitsandrisks.

Ultimately,thebestapproachtomanagingT2DMwilldependontheindividualpatient'sneedsandhealthstatus.Whilesomemayfindreliefintraditionalmedicinesorotheralternativetherapies,othersmaybenefitmostfromtraditionalmedicationsandlifestylemodifications.Byworkingcloselywithahealthcareproviderandstayinginformedaboutthelatestresearchandtreatmentoptions,patientscantakechargeoftheirT2DMmanagementandworktowardsachievingoptimalhealthandwell-being。ForindividualswithType2Diabetes(T2DM),propermanagementoftheconditioniscrucialformaintaininggoodhealthandpreventinglong-termcomplications.ThemosteffectiveapproachtomanagingT2DMwilldependonseveralfactors,includingthepatient'soverallhealthstatus,lifestylehabits,andpersonalpreferences.Inthisarticle,we'llexploresomeofthemostcommonapproachestomanagingT2DM,includingtraditionalmedicines,alternativetherapies,andlifestylemodifications.

TraditionalMedications

ThecornerstoneofT2DMmanagementistypicallymedication,includingoralmedicationsthathelptolowerbloodsugarlevelsandinsulininjectionstomanageinsulinresistance.ThemostcommonlyprescribedoralmedicationsforT2DMincludemetformin,sulfonylureas,andDPP-4inhibitors.Insulininjectionsareoftenusedinmoreadvancedstagesoftheconditionwhenothermedicationsarenolongereffective.

It'simportanttonotethatnotallT2DMmedicationsarethesame,andsomemaybemoreeffectivethanothersdependingonanindividual'sspecifichealthneedsandgoals.Ahealthcareprovidercanhelpdeterminewhichmedicationsarebestsuitedforeachpatient.

AlternativeTherapies

AlternativetherapiesareoftenusedbyindividualswithT2DMwhoareseekingadditionalrelieforwhomaynotberespondingwelltotraditionalmedications.Whilethereislimitedscientificevidencetosupporttheeffectivenessofmanyalternativetherapies,someindividualsmayfindthemhelpfulwhenusedinconjunctionwithtraditionalmedicationsandlifestylemodifications.

SomepopularalternativetherapiesforT2DMincludeacupuncture,massagetherapy,andherbalremediessuchascinnamon,fenugreek,andbittermelon.It'simportanttonotethatalternativetherapiesshouldneverbeusedinplaceoftraditionalmedicationswithouttheguidanceofahealthcareprovider.

LifestyleModifications

HealthylifestylehabitsareacrucialcomponentofT2DMmanagementandcanhelptoimprovebloodsugarcontrol,reducetheriskofcomplications,andimproveoverallhealthandwell-being.SomeofthemostcommonlifestylemodificationsforT2DMinclude:

1.HealthyEating

AhealthydietisvitalforindividualswithT2DM.Adietrichinwholegrains,leanproteins,fruits,andvegetablescanhelptoregulatebloodsugarlevelsandreducetheriskofcomplications.It'salsoessentialtoavoidfoodshighinsugar,saturatedfats,andrefinedcarbohydratesthatcanspikebloodsugarlevels.

2.RegularExercise

Regularexerciseisanothercrucialco

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論